Canopy Growth Stock News

Canopy Growth: Insight Into Upcoming Q3-2022 Earnings

Canopy Growth Corporation (NASDAQ:CGC) price is hovering higher on Monday, February 07, jumping 3.95% above its previous close. >> 7 Top Picks for the Post-Pandemic Economy > 7 Top Picks for the Post-Pandemic Economy

Before markets open Wednesday we will hear earnings results from a key uranium miner, a struggling marijuana grower and a pharmacy/health care services giant.

Merger Monday was living up to its name, as Frontier Airlines has announced a merger with Spirit Airlines aimed at creating the lowest-cost U.S.

Massive rights agreements should set the tone going forward but not everyone is convinced just yet

Marijuana stocks in Canada continue to tumble as fierce competition prevents the big brands on U.S exchanges from capturing a larger share of the Canadian market. So, which Canadian marijuana stocks s

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is shaping up as we k

Canadian Marijuana Stocks For Your 2022 Watchlist The post 2 Canadian Marijuana Stocks To Watch Right Now appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industr

Columbia Care Inc. and Trulieve Cannabis Corp. announced separate debt deals in recent days as cannabis companies turn away from issuing stock to raise capital in the face of weak share prices.

New product launches across the CBD product portfolio and robust demand for legal cannabis products are likely to drive Canopy Growth's (CGC) Q3 top line.

Marijuana banking legislation advances in the House. But will it make a difference?

Canopy Growth Corporation (NASDAQ: CGC ) and Tilray, Inc (NASDAQ: TLRY ) soared 10.59% and 8.76%, respectively, on Monday. The overall sector has been all but demolished since the high times of 2018, when Canada legalized cannabis at the federal level, and the beginning of 2021, when President Joe Bidens inauguration led many to believe federal legalization in the U.S. may be on the horizon. Canopy Growth Corporation has plummeted 86% from its Oct. 16, 2018 all-time high of $59.25, while Tilray has plunged about 98% from its Sept. 19, 2018 all-time high of $300. Although the stocks shot up again in February 2021, with Canopy Growth reaching a high of $56.50 and Tilray soaring up to the $67 level on Feb. 10, the sector has failed to sustain any long-term bull cycle. If neither a continued bounce nor bull cycle takes place, the stocks are beginning to show some characteristics that could make them candidates for a short squeeze. Canopy Growth comes in as a better candidate for a squeeze, with 18.13% of its float held short compared to Tilray, which has 13.16% of its float held short.

Cannara’s Valleyfield Facility This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. In the fall of 2018, Canada became the second country in the world to legalize the recreational use of marijuana . Since that time the Canadian cannabis industry has grown dramatically. Last year saw revenues top $3 billion, and that number is expected to double by 2026, according to Statista.com. These massive revenues have been driven by first movers in the Canadian market like Tilray Inc. (NASDAQ: TLRY ), Canopy Growth Corp. (NASDAQ: CGC ), and Cronos Group Inc. (NASDAQ: CRON ). These producers represent what … Full story available on Benzinga.com

BioSteel Sports Nutrition Inc., which is part-owned by Canopy Growth Corporation CGC announced a series of new deals with retailers that bring the brand's lineup of Clean. Healthy. Hydration.

The marijuana investment is hurting the core alcohol business.